GlobeNewswire - Prospectus, Announcement Of Prospectus

The Flowr Corporation Announces $10 Million Bought Deal Public Offering

Wed, 10 Feb 2021 21:31 GMT

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

Polar Power, Inc. Announces Closing of Public Offering

Wed, 10 Feb 2021 21:05 GMT

GARDENA, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Polar Power, Inc. (Nasdaq: POLA), today announced the closing of its previously announced public offering of 750,000 shares of its common stock at a public offering price of $18.00 per share, for gross proceeds of $13,500,000, before deducting underwriting discounts and offering expenses.

Revive Therapeutics Receives Receipt for Final Short-Form Prospectus for Previously Announced $20 Million Bought Deal Public Offering

Tue, 09 Feb 2021 22:00 GMT

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

ARHT Announces Overnight Marketed Equity Financing

Tue, 09 Feb 2021 16:12 GMT

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR?DISSEMINATION IN THE UNITED STATES

Enservco Corporation Announces Pricing of $8.4 Million Public Offering

Tue, 09 Feb 2021 13:30 GMT

DENVER, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Enservco Corporation (NYSE American: ENSV), a diversified national provider of specialized well-site services to the domestic onshore conventional and unconventional oil and gas industries, today announced the pricing of its public offering of 3,652,173 shares of common stock at a price to the public of $2.30 per share. Enservco expects to receive gross proceeds of approximately $8.4 million, before deducting underwriting discounts and commissions and other estimated offering expenses.

Orientering om kommende prospektopdatering for Sparinvest SICAV, herunder navne?ndring for 4 afdelinger

Tue, 09 Feb 2021 10:45 GMT

Sparinvest S.A. offentligg?r hermed meddelelse om en kommende opdatering af prospektet for Sparinvest SICAV. Prospekt?ndringerne forventes at tr?de i kraft den 9. marts 2021.

Opdateret prospekt for V?rdipapirfonden Sparindex

Fri, 05 Feb 2021 10:33 GMT

ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg offentligg?r opdateret prospekt for V?rdipapirfonden Sparindex med tilh?rende afdelinger.

CORRECTION – Itamar Medical Announces Proposed Offering of American Depositary Shares

Thu, 04 Feb 2021 22:16 GMT

CAESAREA, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Thursday, February 4th by Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), please note that the contact information was incorrect. The corrected release follows:

Itamar Medical Announces Proposed Offering of American Depositary Shares

Thu, 04 Feb 2021 21:01 GMT

CAESAREA, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (“Itamar Medical” or the “Company”) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the commencement of a proposed public offering of American Depositary Shares (“ADSs”) of the Company. Each ADS represents 30 ordinary shares of the Company. The ADSs to be sold in the offering will be offered by the Company and one of its shareholders, Viola Growth 2 A.V. Limited Partnership (the “Selling Shareholder”). The Company and the Selling Shareholder intend to grant to the underwriters a 30-day option to purchase up to an additional 15% of the ADSs being offered on the same terms and conditions. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.

Offentligg?relse af prospekt for Investeringsforeningen Danske Invest og Investeringsforeningen Danske Invest Select

Wed, 03 Feb 2021 08:02 GMT

Vi skal herved oplyse, at der er foretaget ?ndringer i prospekterne for Investeringsforeningen Danske Invest og Investeringsforeningen Danske Invest Select.

Outlook Therapeutics Announces Closing of $35.0 Million Bought Deal

Tue, 02 Feb 2021 21:05 GMT

MONMOUTH JUNCTION, N.J., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“Outlook Therapeutics”), a?late clinical-stage?biopharmaceutical company?working to develop the first FDA-approved ophthalmic formulation of bevacizumab-vikg for use in retinal indications, today announced the closing of its previously announced underwritten public offering of 35,000,000 shares of common stock of the Company at a price to the public of $1.00 per share. As previously announced, the company has granted the underwriter a 30-day option to purchase up to 5,250,000 additional shares of its common stock at the public offering price, less underwriting discounts and commissions.

Neuronetics Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Tue, 02 Feb 2021 21:05 GMT

MALVERN, Pa., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced the closing of an underwritten public offering of 5,566,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase up to an additional 726,000 shares of common stock, at a public offering price of $15.50 per share. Net proceeds from the offering were approximately $80.6 million, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company.

Nyt referenceindeks i SKAGEN Avkastning

Mon, 01 Feb 2021 08:00 GMT

SKAGEN Avkastning skifter referenceindeks d. 1. februar 2021. ?rsagen til ?ndringen er, at b?rsen i Oslo, som hidtil har leveret indekset, med udgangen af januar 2021 ikke leverer dette l?ngere.

Neuronetics Announces Pricing of $75 Million Public Offering of Common Stock

Fri, 29 Jan 2021 03:30 GMT

MALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it has priced the previously announced underwritten public offering of 4,840,000 shares of its common stock, at a public offering price of $15.50 per share. The Company has granted the underwriters a 30-day option to purchase up to an additional 726,000 shares of its common stock. The gross proceeds to the Company from this offering are expected to be approximately $75.0 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. The offering is expected to close on or about February 2, 2021, subject to satisfaction of customary closing conditions.

VSiN, The Sports Betting Network, to Deliver the Deepest Big Game Coverage Ever Available to Sports Betting Fans

Thu, 28 Jan 2021 15:00 GMT

Network’s Offering Represents the Most In-Depth Coverage of the Expanding Betting Markets for What is Expected to Be the Most Bet U.S. Sporting Event in History

Network’s Offering Represents the Most In-Depth Coverage of the Expanding Betting Markets for What is Expected to Be the Most Bet U.S. Sporting Event in History

Seer Announces Pricing of Upsized Public Offering of Common Stock

Thu, 28 Jan 2021 03:51 GMT

REDWOOD CITY, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the pricing of an underwritten public offering of 3,750,000 shares of Class A common stock (1,650,000 of which are being offered for sale by Seer and 2,100,000 are being offered for sale by selling stockholders of Seer) at a public offering price of $67.00 per share. In addition, the selling stockholders of Seer have granted the underwriters a 30-day option to purchase up to 562,500 additional shares of Class A common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about February 1, 2021, subject to satisfaction of customary closing conditions. Seer will not receive any proceeds from the sale of shares in the offering by selling stockholders.

Sunrun Inc. Announces Proposed Private Offering of $350 Million of Convertible Senior Notes

Mon, 25 Jan 2021 12:00 GMT

SAN FRANCISCO, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Sunrun Inc. (Nasdaq: RUN) (“Sunrun”) today announced that it intends to offer, subject to market conditions and other factors,?$350 million?aggregate principal amount of convertible senior notes due 2026 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Sunrun also intends to grant the initial purchasers of the notes the option to purchase up to an additional $50 million aggregate principal amount of the notes within a 13-day period beginning on, and including, the date on which the notes are first issued.

Lithium Americas Closes US$400 Million Underwritten Public Offering

Fri, 22 Jan 2021 15:42 GMT

VANCOUVER, British Columbia, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) ("Lithium Americas" or the "Company") announced today the closing of its previously announced underwritten public offering (the “Offering”) of shares of its common stock (the “Common Shares”). The Company issued 18,181,818 Common Shares, including 2,272,727 Common Shares following the exercise in full by the underwriters of their over-allotment option. The shares were issued at a price of US$22.00 per Common Share for gross proceeds to the Company of approximately US$400 million.

21Vianet Announces Pricing of Offering of US$525 million Convertible Senior Notes

Fri, 22 Jan 2021 13:30 GMT

BEIJING, Jan. 22, 2021 (GLOBE NEWSWIRE) -- 21Vianet Group, Inc. (Nasdaq: VNET) (“21Vianet” or the “Company”), a leading carrier-neutral and cloud-neutral data center services provider in China, today announced the pricing of its previously announced offering (the “Notes Offering”) of US$525 million in aggregate principal amount of convertible senior notes due 2026 (the “Notes”). The Company granted the initial purchasers in the Notes Offering a 13-day option to purchase up to an additional US$75 million in aggregate principal amount of the Notes. The Company plans to use the net proceeds from the Notes Offering for expanding data center infrastructure, repaying the Company’s outstanding senior notes due 2021 and other general corporate purposes.

Global Ship Lease Announces Commencement of Public Offering of Class A Common Shares

Thu, 21 Jan 2021 21:01 GMT

LONDON, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Global Ship Lease, Inc. (NYSE: GSL) (the “Company”) announced today that it intends to commence an underwritten public offering (the “Offering”) of its Class A common shares, par value $0.01 per share (the “Common Shares”). The net proceeds of the Offering are expected to be used for funding the expansion of the Company’s fleet, general corporate purposes, and working capital.